{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:03:10Z","timestamp":1777971790925,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Secretar\u00eda de Ciencia y T\u00e9cnica de la Universidad Nacional de C\u00f3rdoba"},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jpba.2017.10.038","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T01:15:59Z","timestamp":1509585359000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Characterization of systems with amino-acids and oligosaccharides as modifiers of biopharmaceutical properties of furosemide"],"prefix":"10.1016","volume":"149","author":[{"given":"Julieta Abraham","family":"Miranda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Garnero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana","family":"Zoppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Sterren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro P.","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela R.","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2017.10.038_bib0005","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.biotechadv.2014.07.006","article-title":"A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules","volume":"32","author":"Choonara","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jpba.2017.10.038_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/926157","article-title":"Alginate particles as platform for drug delivery by the oral route: state-of-the-Art","author":"Sosnik","year":"2014","journal-title":"ISRN Pharmaceutics"},{"key":"10.1016\/j.jpba.2017.10.038_bib0015","article-title":"Solubility enhancement strategies for poorly water soluble drugs in solid dispersion: a review","volume":"1","author":"Sharma","year":"2007","journal-title":"Asian J. Pharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0020","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejps.2016.10.035","article-title":"Pharmaceutical salts of ethionamide with GRAS counter ion donors to enhance the solubility","volume":"96","author":"Nechipadappu","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.10.038_bib0025","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.drudis.2015.11.017","article-title":"Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex","volume":"21","author":"Jambhekar","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpba.2017.10.038_bib0030","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1039\/C6CC00898D","article-title":"How cocrystals of weakly basic drugs and acidic coformers might modulate solubility and stability","volume":"52","author":"Kuminek","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jpba.2017.10.038_bib0035","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejpb.2013.03.026","article-title":"Amino acids as co-amorphous stabilizers for poorly water-soluble drugs \u2013 part 2: molecular interactions","volume":"85","author":"L\u00f6bmann","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0040","first-page":"2013","article-title":"Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs","author":"Xu","year":"2013","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jpba.2017.10.038_bib0045","first-page":"1","article-title":"Nanosystems for drug delivery","volume":"2","author":"Caban","year":"2014","journal-title":"OA Drug Des. Deliv."},{"key":"10.1016\/j.jpba.2017.10.038_bib0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.powtec.2016.09.084","article-title":"Palmitoylethanolamide sub-micronization using fast precipitation followed by supercritical fluids extraction","volume":"305","author":"Campardelli","year":"2017","journal-title":"Powder Technol."},{"key":"10.1016\/j.jpba.2017.10.038_bib0055","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.3390\/molecules201018759","article-title":"Polymorph impact on the bioavailability and stability of poorly soluble drugs","volume":"20","author":"Censi","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2017.10.038_bib0060","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejmech.2013.11.045","article-title":"Pharmaceutical salts and cocrystals involving amino acids: a brief structural overview of the state-of-art","volume":"74","author":"Tilborg","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpba.2017.10.038_bib0065","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/17425247.2014.911728","article-title":"Refining stability and dissolution rate of amorphous drug formulations","volume":"11","author":"Grohganz","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jpba.2017.10.038_bib0070","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1021\/mp500107s","article-title":"Amino acids as Co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability","volume":"11","author":"Laitinen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0075","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-017-0775-4","article-title":"Preparation of Chloramphenicol\/Amino acid combinations exhibiting enhanced dissolution rates and reduced drug-induced oxidative stress","author":"Sterren","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpba.2017.10.038_bib0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejpb.2015.07.011","article-title":"Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine","volume":"96","author":"Lenz","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2017.01.066","article-title":"Potential of single cationic amino acid molecule arginine for stimulating oral absorption of insulin","volume":"521","author":"Kamei","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0090","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.carbpol.2013.07.070","article-title":"Physicochemical and molecular modeling studies of cefixime\u2013L-arginine\u2013cyclodextrin ternary inclusion compounds","volume":"98","author":"Jadhav","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jpba.2017.10.038_bib0095","first-page":"281","article-title":"Preparation and characterization of piroxicam alkali-salt \u03b2-cyclodextrin complexes, proceed 9th intern symp cyclodextrins, dordrecht","author":"Vikmon","year":"1999","journal-title":"Ger. Kluwer Acad. Publ."},{"key":"10.1016\/j.jpba.2017.10.038_bib0100","first-page":"979","article-title":"Cyclodextrin complexes of salts of acidic drugs","volume":"90","author":"Redenti","year":"2001","journal-title":"Thermodyn. Prop. Struct. Features Pharm. Appl."},{"key":"10.1016\/j.jpba.2017.10.038_bib0105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/js960298k","article-title":"Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-L \u2013Lysine-cyclodextrin complexes","volume":"86","author":"Piel","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.10.038_bib0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0378-5173(03)00265-5","article-title":"Ternary systems of naproxen with hydroxypropyl-\u03b2-cyclodextrin and aminoacids","volume":"260","author":"Mura","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejpb.2004.05.005","article-title":"Solid-state characterization and dissolution properties of Naproxen \u2013Arginine -Hydroxypropyl-\u03b2-cyclodextrin ternary system","volume":"59","author":"Mura","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0120","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-009-9375-2","article-title":"The role of l \u2013arginine in inclusion complexes of omeprazole with cyclodextrins","volume":"11","author":"Figueiras","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpba.2017.10.038_bib0125","series-title":"The Biopharmaceutics Classification Systems (BCS) Guidance","article-title":"Center for drug evaluation and research (CDER)","author":"FDA","year":"2001"},{"key":"10.1016\/j.jpba.2017.10.038_bib0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijpharm.2015.05.063","article-title":"Stabilisation of amorphous furosemide increases the oral drug bioavailability in rats","volume":"490","author":"Nielsen","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.carbpol.2016.07.006","article-title":"Stability of furosemide polymorphs and the effects of complex formation with \u03b2-cyclodextrin and maltodextrin","volume":"152","author":"Garnero","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jpba.2017.10.038_bib0140","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejmech.2013.11.045","article-title":"Pharmaceutical salts and cocrystals involving amino acids: a brief structural overview of the state-of-art","volume":"74","author":"Tilborg","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpba.2017.10.038_bib0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.foodchem.2013.12.067","article-title":"Curcumin-\u03b2-cyclodextrin inclusion complex: stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction and photoacoustic spectroscopy, and food application","volume":"153","author":"Mangolim","year":"2014","journal-title":"Food Chem."},{"key":"10.1016\/j.jpba.2017.10.038_bib0150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1515\/chempap-2015-0078","article-title":"\u03b2-Cyclodextrin as water-solubility enhancer for butylated hydroxytoluene","volume":"69","author":"Lukasiewicz","year":"2015","journal-title":"Chem. Pap."},{"key":"10.1016\/j.jpba.2017.10.038_bib0155","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/jf304047g","article-title":"Microencapsulation by freeze-drying of potassium norbixinate and curcumin with maltodextrin: stability, solubility, and food application","volume":"61","author":"Sousdaleff","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jpba.2017.10.038_bib0160","first-page":"117","article-title":"Phase-Solubility techniques in advances in analytical chemistry and instrumentation","volume":"4","author":"Higuchi","year":"1965","journal-title":"Intersci. New York"},{"key":"10.1016\/j.jpba.2017.10.038_bib0165","first-page":"64","article-title":"Mathematical comparison of dissolution profiles","volume":"20","author":"Moore","year":"1996","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.jpba.2017.10.038_bib0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-5173(01)00651-2","article-title":"An alternative method to the evaluation of similarity factor in dissolution testing","volume":"220","author":"Costa","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0175","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.carbpol.2013.01.055","article-title":"Supramolecular complexes of maltodextrin and furosemide polymorphs: a new approach for delivery systems","volume":"94","author":"Garnero","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jpba.2017.10.038_bib0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpba.2014.02.017","article-title":"Improving furosemide polymorphs properties through supramolecular complexes of \u03b2-cyclodextrin","volume":"95","author":"Garnero","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.10.038_bib0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2016.06.020","article-title":"Influence of variation in molar ratio on co-amorphous drug-amino acid systems","volume":"107","author":"Jensen","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(88)90225-6","article-title":"Frusemide crystal forms; solids state and physicochemical analyses","volume":"47","author":"Doherty","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/cg2013232","article-title":"Polymorphs and a hydrate of furosemide-Nicotinamide 1: 1 cocrystal","volume":"12","author":"Ueto","year":"2012","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.jpba.2017.10.038_bib0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0378-5173(90)90185-7","article-title":"Physicochemical characterization of furosemide modifications","volume":"60","author":"Matsuda","year":"1990","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2017.10.038_bib0205","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1021\/cg100098z","article-title":"Conformational and synthon polymorphism in furosemide (Lasix)","volume":"10","author":"Babu","year":"2010","journal-title":"Cryst. Growth Des."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517320678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517320678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T08:15:38Z","timestamp":1536308138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517320678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":41,"alternative-id":["S0731708517320678"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.10.038","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of systems with amino-acids and oligosaccharides as modifiers of biopharmaceutical properties of furosemide","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}